Ceribell
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Ceribell sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Ceribell: 4 sponsored US clinical trials, 2 recruiting.
Ceribell sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Delirium, with 1 trials.
Upper-quartile sponsor footprint
Ceribell sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
NCT07485244
Ceribell Delirium Data Collection Study
NCT04962815
Ceribell Delirium Monitor Outcomes Pilot Study
NCT07449416
Does Use of Rapid Response EEG Impact Clinical Decision Making
NCT03534258
Therapeutic Areas
What is open in the Ceribell pipeline
2 recruiting of 4 indexed (50% open); 1 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Delirium (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ceribell: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Ceribell sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Ceribell page
4 registered trials is a research-attention snapshot, not an endorsement of Ceribell or any single study.
- 2 of Ceribell's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Delirium is the condition Ceribell studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Delirium trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ceribell pipeline card: 4 registered trials from official public datasets.Report a data error.